首页 › 基金 › Vestal Point Capital, LP › AVTX
Vestal Point Capital, LP 对 AVTX 的持仓历史
AVALO THERAPEUTICS INC · 医疗保健
Vestal Point Capital, LP 在 Q3 2026 的 13F 申报中披露持有 AVTX(AVALO THERAPEUTICS INC)800,000 股,市值约 US$12.3M,约占其申报组合的 0.32%,在其申报持仓中市值排名第 36 位。 Vestal Point Capital, LP 最近 2 个申报季度中有 2 个季度披露了 AVTX 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Vestal Point Capital, LP 对 AVTX 的持仓演变
Vestal Point Capital, LP 于 Q2 2026 首次披露 AVTX 持仓:775,000 股(约 US$14.3M)。 在 2 次申报中,Vestal Point Capital, LP 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 800,000 股、市值约 US$12.3M,环比增持 25,000 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 775.00K | $14.32M | 新进 |
| Q3 2026 | 800.00K | $12.26M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 AVTX 与 13F 数据
AVTX(AVALO THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 68 只申报持有 AVTX,申报仓位最大的包括:FARALLON CAPITAL MANAGEMENT, L.L.C. (US$60.9M), Deep Track Capital, LP (US$55.3M), Caligan Partners LP (US$50.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 AVTX 的基金
- FARALLON CAPITAL MANAGEMENT, L.L.C. 3.97M 股 · $60.92M · Q3 2026
- Deep Track Capital, LP 3.61M 股 · $55.34M · Q3 2026
- Caligan Partners LP 3.27M 股 · $50.10M · Q3 2026
- Affinity Asset Advisors, LLC 3.24M 股 · $49.74M · Q3 2026
- TCG Crossover Management, LLC 3.02M 股 · $46.25M · Q3 2026
- 法拉龙资本管理 2.50M 股 · $46.16M · Q2 2026
- Avoro Capital Advisors LLC 2.38M 股 · $36.45M · Q3 2026
- Nantahala Capital Management, LLC 2.14M 股 · $32.84M · Q3 2026
- BRAIDWELL LP 1.61M 股 · $24.67M · Q3 2026
- Logos Global Management LP 1.50M 股 · $23.00M · Q3 2026
- Trails Edge Capital Partners, LP 1.50M 股 · $23.00M · Q3 2026
- Commodore Capital LP 1.02M 股 · $15.61M · Q3 2026
更多关于 Vestal Point Capital, LP
常见问题
How long has Vestal Point Capital, LP held AVTX?
Vestal Point Capital, LP has disclosed AVTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Vestal Point Capital, LP's current position in AVTX?
As of Q3 2026, Vestal Point Capital, LP holds 800.00K shares of AVTX (AVALO THERAPEUTICS INC), valued at $12.26M, representing 0.32% of its reported portfolio and ranking #36.
Has Vestal Point Capital, LP been buying or selling AVTX?
In the latest 13F filing (Q3 2026), Vestal Point Capital, LP increased its position in AVTX.
Which other funds hold AVTX?
Other major institutional holders of AVTX include FARALLON CAPITAL MANAGEMENT, L.L.C., Deep Track Capital, LP, Caligan Partners LP, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.